oncoarray:analysis_groups
Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
oncoarray:analysis_groups [2015/07/13 17:52] – created 129.170.59.116 | oncoarray:analysis_groups [2019/08/29 23:17] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ====== Dartmouth ====== | ||
+ | * Lung - Chris Amos, Jinyoung Byun, Xiangjun Xiao | ||
+ | * Glioma - 8,000 samples - ?? | ||
+ | ====== USC ====== | ||
+ | * Colorectal - Fred Schumacher, Christopher Edlund | ||
+ | * Prostate - 17,000 samples - Chris Haiman, David Conti | ||
+ | |||
+ | ====== Cambridge ====== | ||
+ | * Breast - 150,000 samples - Doug Easton, Kyriaki Michailidou | ||
+ | * Ovarian - 57,000 samples - Paul Pharoah, Jon Tyrer, Ailith Pirie | ||
+ | * Prostate - 100,000 samples - Ali Amin, Sara Benlloch | ||
+ | * BRCA 1/2 carriers -31,000 samples - Antonis Antoniou, Karoline Kuchenbaecker, | ||
+ | * Endometrial - Deborah Thompson | ||
+ | * Other Sites being QC'ed in Cambridge (Bladder, Cervical, Lung, Head and Neck, Pancreas) - 5,000 samples - Laura Fachal | ||
+ | |||
+ | ===== Email group for Oncoarray analysis emails ===== | ||
+ | jgd29@cam.ac.uk, |